Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • cm0002@lemmy.worldEnglish
    5·
    1 year ago

    Well if it helps accelerate the development of life saving medications I suppose it’s the least offensive use of that data.

    Much preferred over say insurance companies using it or hostile governments lmao

      • Szymon@lemmy.caEnglish
        3·
        1 year ago

        If you can keep someone from dying by being dependent on only your medication, you’ve created a customer for life rather than one who died and didn’t give you all their money to live another day.

    • BURN@lemmy.worldEnglish
      21·
      1 year ago

      We all know it won’t stop there. Once they have it they’re going to make as much money off of it as possible.

      I’m pretty sure insurance companies already have some kind of access to this stuff, despite saying they don’t.